Related Experiment Video
Updated: Jul 15, 2026
08:17
Generation of a Chronic Obstructive Pulmonary Disease Model in Mice by Repeated Ozone Exposure
Published on: August 25, 2017
[Oxidative stress in pathogenesis of COPD]
1First Department of Medicine, Hokkaido University, School of Medicine.
Nihon Rinsho. Japanese Journal of Clinical Medicine
|April 11, 2007
Summary
Long-term smoking and aging accelerate lung damage in chronic obstructive pulmonary disease (COPD). Evaluating the glutathione antioxidant system in smokers reveals molecular changes predisposing lungs to emphysema.
Area of Science:
- Pulmonary Medicine
- Environmental Health
- Biochemistry
Context:
- Chronic obstructive pulmonary disease (COPD) is strongly linked to cigarette smoke exposure and aging.
- The lung's interaction with the environment involves oxidative stress, countered by systems like glutathione.
- Understanding molecular responses to long-term smoking and aging is crucial for COPD pathogenesis.
Purpose:
- To investigate the impact of long-term smoking and aging on the lung's glutathione antioxidant system.
- To compare molecular responses in different age groups of smokers and non-smokers, with and without emphysema.
- To identify potential therapeutic targets for COPD by understanding protective mechanisms.
Summary:
- Bronchoalveolar lavage fluid was analyzed from non-smokers and smokers of various ages, categorized by emphysema presence on CT scans.
- The study evaluated the glutathione antioxidant system in the bronchoalveolar lavage fluid.
- Findings suggest that older smokers with long smoking histories exhibit molecular changes that may explain susceptibility to lung diseases like emphysema.
Impact:
- Characterizing molecular differences in older versus younger smokers provides insights into COPD development.
- Oxidative stress, arising from aerobic metabolism imbalance, contributes to emphysematous lung destruction.
- Targeted upregulation of protective mechanisms, like the glutathione system, may be key for future COPD therapies.
Related Concept Videos
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
01:23Chronic Obstructive Pulmonary Disease II: Emphysema
Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
01:20COPD: Pathogenesis and Clinical Features
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
01:23Chronic Obstructive Pulmonary Disease I: Introduction
Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
01:24Chronic Obstructive Pulmonary Disease
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
01:24Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...